Stock Information
Lineage Cell Therapeutics Inc (LCTX)
Ticker Symbol: LCTX
Exchange: NYSE
Sector: Biotechnology
Market Cap: $438.44 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -0.2782
Revenue (TTM): $0.06 M
Dividend Yield: N/A%
ROE: -130.99%
Latest News
-
Lineage Cell Therapeutics Expands Cell Transplant Pipeline With COR1
Tue, Mar 24, 2026 8:07 AM
-
12 Health Care Stocks Moving In Wednesday's After-Market Session
Wed, Mar 18, 2026 5:05 PM
Key Financials
Financial data not available
